Webinar
BBA Webinar: Pretrial and Compassionate Release During COVID-19: A Focus on White Collar Defendants in the Federal Courts
19 May 2020
Gregory F. Noonan
PartnerBoston
Email [email protected]hoganlovells.com
Phone +1 617 371 1029
Fax +1 617 371 1037
Practice groupLitigation, Arbitration, and Employment
Greg Noonan represents both corporations and individuals in a broad range of white collar criminal and complex civil matters, including government investigations and enforcement, internal investigations, and qui tam litigation.
Greg's experience is broad, including defending alleged violations of, for example, the False Claims Act (FCA); the Anti-Kickback Statute; the Food, Drug, and Cosmetic Act; and the Health Insurance Portability and Accountability Act (HIPAA). His clients include companies and professionals in the pharmaceutical, medical device, and health care industries, as well as in financial services, higher education, and high tech.
Before joining the firm, Greg served as an Assistant U.S. Attorney (AUSA) from 2008 through 2012 for the U.S. Attorney's Offices in the District of Massachusetts and the Southern District of California. In Boston, Greg was a member of the criminal Health Care Fraud Unit. In San Diego, Greg was a member of the General Crimes Unit.
In addition to his legal practice, Greg currently also serves as the Boston Office Administrative Partner and its Litigation, Arbitration, and Employment group manager.
Awards and recognitions
2017-2020
Criminal Defense: White Collar
Massachusetts Super Lawyers
Education and admissions
Education
J.D., Harvard Law School, 2001
B.S.F.S., Georgetown University, School of Foreign Service, magna cum laude, 1998
Memberships
Boston Bar Association
American Bar Association
Bar admissions and qualifications
Massachusetts
California (inactive)
Court admissions
U.S. District Court, District of Massachusetts
U.S. District Court, Central District of California
U.S. Court of Appeals, First Circuit
U.S. Court of Appeals, Ninth Circuit
Representative experience
Represented pharmaceutical executive in successful resolution of criminal allegations in off-label and HIPAA investigations, civil allegations in FCA qui tam case, and securities class action.
Resolved state attorney general investigation of state-mandated student disclosures for online school system.
Represented pharmaceutical manufacturers in various off-label promotion investigations.*
Represented medical device manufacturer in False Claims Act and Anti-Kickback Statute investigation.*
Secured civil settlement for individual investigated for submitting false claims to Medicare.*
*Matter handled prior to joining Hogan Lovells.
Latest thinking and events
Hogan Lovells Publications
Podcast series: False Claims Act 2019 and the road ahead Hogan Lovells
04 March 2020
Analysis
ADG Insights: Roadmap for False Claims Act enforcement in 2020
Registered Content
31 January 2020
Hogan Lovells Publications
FCA Guide: 2019 and the road ahead Hogan Lovells
22 January 2020
Announcements
Hogan Lovells appoints Maria Durant and Greg Noonan to lead the Boston office
10 January 2020
Webinar
BBA Webinar: HIPAAtheticals: HIPAA in the promotional context
November 13, 2019
